Managing Director of MSD Greece, Cyprus & Malta Agata Jakoncic, who also serves as president of Greece’s PhRMA Innovation Forum (PIF), draws on her three decades of industry experience to outline some of the key challenges in the Greek pharma market today which threaten its sustainability and the ability of Greek patients to access lifesaving medicines. Jakoncic also highlights how inter-stakeholder collaboration and better data utilisation could bolster sustainability in Greek healthcare and provide win-win solutions across the board.
The way our system has developed means that either we all win together, or we all lose together. Collaboration, therefore, is the key to future success
